Skip to main content
Up to 53% offSee the plans

News | Stocks | Iran

Razak Laboratories (DRZK) Discloses Higher Average Selling Prices for Human and Veterinary Medicines

Sahmino Newsroom | 11 November 2026 | 10 days ago

DRZKup3.0%7,670rials18 November

Razak Laboratories (DRZK) said in its group-A Codal disclosure, tracking number 1613965, published Wednesday 11 November 2026, that the average selling price of 16 human and veterinary medicine products rose 64% from that day, with permission from the Food and Drug Organization and a trade association. The company attributed the change to higher raw-material costs.

Razak said those products accounted for 15% of total revenue in its previous fiscal year. Its disclosure table shows zero for the old and new price fields and does not list prices for individual products; the announced average increase therefore cannot be applied to all company sales. The notice reports a change in selling rates, not an increase in realized sales or profit.

Reference:CodalThe original report

Sahmino context

What the prices have done since this story was published, and what Sahmino wrote around it

More from this market